Benzonatate Capsule
Product Images NDC 42708-171

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Benzonatate (NDC 42708-171). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qpharma Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

42708-171-21 (42708 171 21 Rev 1)

42708-171-21 (42708 171 21   Rev 1)
Label for Benzonatate Capsules USP, 200 mg oral capsules, containing 21 capsules. The label shows the NDC 42708-171-21, lot and expiration date fields, and directions for use with blanks to fill in dosage and frequency. Distributed by QPharma, Inc., Cedar Knolls, NJ. Storage instructions note to keep at controlled room temperature and keep container tightly closed out of reach of children. Marked Rx only.*
FDA Label Image

Structure Formula (Structure Formula)

Structure Formula (Structure Formula)
Chemical structure of Benzonatate showing the molecular formula C30H53NO11 with a phenyl ring and various functional groups including an amine and ether linkages.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.